Introduction
Conjunctivitis is the most common ocular disease worldwide (Adebayo et al., 2011; Hovding, 2008; McDonell, 1988; Sheikh & Hurwitz, 2005) . The disease can be divided into acute, hyperacute and chronic conjunctivitis according to the mode of onset and the severity of the clinical response (Mannis & Plotnic, 2006) .Acute infective conjunctivitis may be viral or bacterial. Acute bacterial conjunctivitis is a common infection of the ocular surface that affects persons of all ages (DeLeon et al, 2012; Sheikh & Hurwitz, 2005) . Most bacterial conjunctivitis are characterized by a self-limited course of inflammation of the conjunctiva with mucopurulent discharge. But in some cases it has the potential for significant ocular morbidity. Rapid destruction of the eye may be enhanced by the presence of purulence in some instances (Adebayo et al, 2011; Hovding, 2008) . Although most cases of conjunctivitis are self limited, treatment with antibiotics has been shown to decrease the discomfort and duration of the symptoms. Antibiotic treatment also reduces contagious spread (Hutnik, Mohammad & Shahi, 2010; Lietman et al, 1984; Morrow & Abbott, 1998; Tarabishy & Jeng, 2008) .Incidence of bacterial conjunctivitis, common pathogens causing it and their susceptibility to existing antibiotics differ from country to country (Adebayo et al, 2011; Azari & Barney, 2013; Haas, Gearinger, Hesje, Sanfilippo, & Morris, 2012; Pichichero, 2011; Sthapit, Tuladhar, Marasini, Khoju, & Thapa, 2011) . Also there is a shifting trend in susceptibility and resistance of the bacteria towards available antibiotics in the last decade (Adebayo et al, 2011) . Therefore, periodic studies to monitor the emerging trends in antibiotic susceptibility and resistance are crucial in guiding antibiotic selection. The aim of this study was to determine the most common pathogens causing bacterial conjunctivitis, and to find the in vitro susceptibility and resistance of these pathogens to commercially available topical antibiotic eye drops in Nepal.
Materials and methods

Study design and participants
It was a hospital based cross-sectional study conducted among 308 patients presenting to the Eye Care Center, Padma Nursing Home, Pokhara, Nepal from 11 th December 1012 to 4 th October 2013 with clinical signs and symptoms of acute infective conjunctivitis. When there were follicles in the lower fornix and lower tarsal conjunctiva along with congestion and secretions/discharges, patients were diagnosed to be suffering from acute follicular conjunctivitis. If there was conjunctival congestion and discharge but no follicles, then a diagnosis of acute infective conjunctivitis was made. Patients with copious mucopurulent discharge were diagnosed to be suffering from mucopurulent conjunctivitis, and children who were less than 1 month of age were diagnosed to be suffering from Ophthalmia neonatorum.
Ethical approval for the study was obtained from the institutional review board at Padma Nursing Home, Pokhara, Nepal. Informed consent was taken from all adult patients and from parents of children included in this study. Patients who were taking systemic antibiotics and steroids for other concurrent systemic diseases and those patients who were already using topical antibiotics or steroids at the time of presentation were excluded from the study. In a pilot study conducted prior to original study with ten patients of Acute Infective Conjunctivitis due to bacterial infection showed proportion of Staphyloccus aureus to be 0.70. So, with significance level 5% and 95% level of confidence required, sample size calculated was 100 (Sathian et al, 2010) . Out of 308 consecutive acute infective conjunctivitis patients examined, 100 had positive bacterial culture.
Results
Out of 308 patients in this study, there were more males 167(54.2%) than females 141(45.8%). Five (1.6%) patients were below 1 month of age, 53(17.2%) were >1 month to ≤2 years of age, 76(24.7%) were >2 years to ≤15 years of age and 174(56.5%) patients were adults(>15 years).About 43.5% of the patients were children(Table -1.).
Similarly, 178(57.79%) patients were diagnosed with acute follicular conjunctivitis, 122(39.61%) were diagnosed with acute infective conjunctivitis, 3(0.97%) diagnosed with mucopurulent conjunctivitis and 5(1.62%) were diagnosed to be suffering from ophthalmia neonatorum ( Table -2 ).
There was no bacterial growth in culture of 208(67.5%) patients. Out of 100 (32.5%) patients in whom bacterial culture was positive, most common organisms were Staph. aureus, which was grown in 60(60.0%) of patients followed by Strept. pneumoniae in 27(27.0%) patients, Methicillin resistant Staphylococcs aureus (MRSA) in 7(7.0%) of patients and E. coli in 4(4.0%) of patients. The least common bacteria grown were Diptheroid bacilli and H. influenzae both of which, were present in 1(1.0%) of the patients with positive bacterial culture ( 
Discussion
In this study, adults were more affected with infective conjunctivitis. Bacterial conjunctivitis was more common in children as compared to viral conjunctivitis which was more common in adults. (Tables 1, 12 ). This finding was similar to those of previous studies (Azari & Barney, 2013; Fitch, Rapoza & Owens, 1989; Harding, Mallinson, Smith & Clearkin, 1987; Hørven, 1993; Rönnerstam, Persson, Hansson, & Renmarker, 1985; Stenson, Newman, & H., 1982; Uchio, Takeuchi, & N, 2000; Woodland, Darougar, & Thaker, 1992 Nepal J Ophthalmol 2015; 8(15): 23-35 diagnosed to have AFC showed positive bacterial culture. In the similar manner, 48.36% of patients diagnosed to have acute infective conjunctivitis(AIC), and 66.67 patients diagnosed clinically as mucopurulent conjunctivitis had negative bacterial culture. These findings support the fact that diagnosis of viral or bacterial conjunctivitis cannot be made on the basis of clinical signs and symptoms only. These findings are similar to previous studies (Azari & Barney, 2013; Rietveld, Ter Riet, Bindels, Sloos & van Weert, 2004; Rietveld, Van Weert, Ter Riet & Bindels, 2003; Tarabishy & Jeng, 2008) .
In this study, 32.47% patients had positive bacterial culture and 36.04% showed organisms in Grams stain (Tables 2-4) . This was in contrast with the earlier study conducted by Sthapit et al in Nepal in 2009-10 in which, they had found organisms in grams stain as well as bacterial growth in 16.9% of their acute infective conjunctivitis patients (Sthapit et al., 2011) .
The most common bacteria causing acute infective conjunctivitis (Table 3) in our study was Staph. aureus (60%) followed by Strept. pneumonia(27%). Less common organisms were E. coli(4%), Diptheroid bacilli(1.0%) and H influenzae(1.0%). It was alarming to note that Methicillin resistant Staph. aureus(7.0%) was on the rise as compared to similar study done few years back in Nepal by Sthapit et al in which the incidence of MRSA was 3.1%. Sthapit et al reported Strept. pneumonia as most common organisms followed by Staph. aureus. The findings of the present study is similar to the findings of Azari and Barney, who after searching literature published through March 2013, using Pubmed, the ISI web of Knowledge database and the Cochrane Library reported that the most common pathogens for bacterial conjunctivitis in adults are Staphylococcal species, followed by Streptococcus pneumoniae and Haemophilus influenzae (Azari & Barney, 2013) . Abedayo et al reviewed records of all conjunctival bacterial cultures performed at New York Eye and Ear Infirmary from 1997 to 2008. They found that Staphyloccus aureus was the most common gram positive pathogen isolated, and also the most commonly isolated pathogen overall. Haemophilus influenzae was the most common gram-negative pathogen isolated (Adebayo et al, 2011) . While their findings was similar to the present study in case of gram positive organisms, in the present study, most common gram negative organism was E. coli. In 2010, Hutnik et al analyzed systematic reviews, meta analyses and randomized controlled trials for bacterial conjunctivitis from 1990 to 2010. Their search sources were from ovid MEDLINE, PubMed, Cochrane Library, NHS evidence and Clinical Evidence. They concluded that bacterial conjunctivitis is caused by Staphyloccus species in adults and by Streptococcus pneumoniae and the Gramnegative organisms Haemophilus influenxae and Moraxella catarrhalis in children (Hutnik et al, 2010) . However, Haas et al (2012) from the USA reported that the most prevalent species in their study was H. influenzae, followed by Staphylococcus epidermidis, Staphylococcus aureus, the Streptococcus mitis group, and Streptococcus pneumoniae. One species identified in this study, which was not previously noted as a common cause of bacterial conjunctivitis was Dolosigranulum pigrum (Haas et al, 2012 ).
Haas and his colleagues conducted a randomized, double masked, vehiclecontrolled, parallel group study in the United States with besifloxacin ophthalmic suspension 0.6% dosed twice daily. They had 496 bacterial isolates. They found that Ampicillin resistance was common among H. influenzae isolates, while macrolide resistance was high among Streptococcus pneumoniae, Staphylococcus epidermidis and Staphyloccus aureus. The latter two species also included a number of isolates resistant to methiciillin and ciprofloxacin.
Abedayo and his colleagues from New York
Eye and Ear Infirmary after analyzing 20,180 conjunctival bacterial cultures (Adebayo et al, 2011) concluded that conjunctival bacterial isolates demonstrated high levels of resistance to tetracycline, erythromycin and TMP/SMZ. According to their study, Moxifloxacin and gatifloxacin appeared to be currently the best choice for empirical broad-spectrum coverage and vancomycin was the best antibiotic for MRSA coverage.
Bacterial resistance to antibiotic therapy can result from a number of factors. Nationwide surveillance studies such as the Ocular Tracking Resistance in US Today (TRUST) survey, and The Surveillance Network (TSN) have documented emerging resistance among ocular pathogens to ocular anti-infectives (Asbell, Colby, et al, 2008; Asbell, Sahm, Shaw, Draghi & Brown, 2008; Pichichero, 2011 (Wald, Greenberg & Hoberman, 2001) . Another study reported an increase in resistance to ciprofloxacin by S aureus isolates from 13.3% to 36.0% and the prevalence of methicillin resistance among these isolates increased concurrently from 4.4% to 42.9% (Cavuoto, Zutshi, Karp, Miller & Feuer, 2008) . More recently, a study of bacterial conjunctivitis isolatesfound that 65% of MRSA isolates were resistant to ciprofloxacin (Pichichero, 2011) .
In the present study, 1.7%, 3.3%, 5.0% and 6.7% of MSSA isolates were resistant to Chloroamphenicol, Polymyxin-B, Neomycin and Bacitracin respectively( Table-6 ). In contrast, plenty of resistances were encountered for MRSA. About 14.% of MRSA were resistant to Amikacin, Tobramycin, and Ciprofloxacin, 28.6% were resistant to Gentamycin and Ofloxacin, 42.9% were resistant to Bacitracin and Neomycin and 85.7% were resistant to Polymyxin-B (Table 8) . Strept. pneumoniae was sensitive to most antibiotics except for three-Bacitracin(.7%), Neomycin(37.0%) and Polymyxin-B(55.6%)( Table 7) . About 25% of E. coli, which were the predominant gram negative isolates in this study, were resistant to Cephazoline, Gentamycin, Vancomycin and Polymyxin-B and 75% were resistant to Bacitracin (Table 9) .One of the isolates Diptheroids bacillus and the other H. influenzae, were sensitive to all thirteen antibiotics tested.
Collectively, most (93 to 98%) bacterial isolates were highly sensitive to most antibiotics used. But these isolates demonstrated significant resistance to three antibiotics-Bacitracin(9.0%), Shrestha SP et al Acute bacterial conjunctivitis Nepal J Ophthalmol 2015; 8(15): 23-35 Neomycin(16.0%) and Polymyxin-B(24%) ( Table 11 ). The best commercially available antibiotic for bacterial conjunctivitis was Moxifloxacin. Therefore, this antibiotic seems to be best choice for patients with bacterial conjunctivitis for all ages. Although resistance is developing with older fluorquinolones (Ciprofloxacin, Ofloxacin), it is less common with newer fluorquinolones (moxifloxacin, gatifloxacin, besifloxacin) because, the newer fluoroquinolones exhibit balanced dual binding of these enzymes and require multi step mutations, whereas resistance to the older fluoroquinolones which typically target one enzyme in preference to the other, may require only a single such mutation (Asbell, Colby et al, 2008; Pichichero, 2011) .
In the present study, five (1.62%) patients of acute infective conjunctivitis were below 1 month of age and were suffering from Ophthalmia neonatorum (Table 1 ,2,10). Among these five patients, E. Coli was isolated in 3, and Staph. aureus were isolated in 2 patients ( Table 2 ). All of them(100.0%) were sensitive to seven antibiotics namely Amikacin, Chloroamphenicol, Ciprofloxacin, Methicillin, Moxifloxacin, Ofloxacin, and Tobramycin. About 20% of them were resistant to Cephazoline, Gentamycin and Vancomycin while, 60% patients in this group were resistant to Bacitracin (Table 10) .
Ophthalmia neonatorum is caused by C. trachomatis, N. gonorrheae, herpes simplx virus (typically HSV-2) and less commonly by Staphylococci, Streptococci, H. influenzae, and various gram negative bacteria (Kanski & Bowling, 2011) . It may be also due to chemicals used at birth. Infections by first three organisms can be serious with disastrous consequences. Therefore, it was good to know that all the cases of ophthalmia neonatorum in this study was caused by bacteria E. coli and Staph. aureus which were sensitive to many antibiotics tested.
Treatment of acute bacterial conjunctivitis with a broad-spectrum, preferably bactericidal, antibacterial is often initiated empirically because the rapid kill of bacteria shortens the time to recovery; limits the spread of disease; relieves a financial burden by speeding up a patient's return to day care or school or work; and reduces the risk of sight-threatening complications.
Conclusions
Acute infective conjunctivitis and viral conjunctivitis was more common in adults and in males. Bacterial conjunctivitis was present in about one third(32.47% to 36.04%) of the patients with acute infective conjunctivitis more common in children than in adults in whom viral conjunctivitis was more common. Bacteria were highly sensitive (93-98%) to most commercially available antibiotics but significant resistance was found against three antibiotics-Bacitracin(9.0%), Neomycin(16.0%) and Polymyxin-B(24.0%). MRSA infection was found in 7.0% of the bacterial isolates. These were sensitive to three antibiotics-chloroamphenicol, Cephazoline and Vancomycin. Rest of antibiotics, showed variable resistance (14.3% to 100.0%). All cases of ophthalmia neonatorum in this series were bacterial and sensitive to most antibiotics tested. The best commercially available antibiotic for bacterial conjunctivitis was Moxifloxacin (99.0% sensitivity).
